Synthesis and Characterization of AP5346, a Novel Polymer-Linked Diaminocyclohexyl Platinum Chemotherapeutic Agent
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rosenberg B., 1965, Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205, 698−699
Weiss R. B., 1993, New cisplatin analogues in developement. A review. Drugs 46, 360−377
Natile G., 2001, Coord. Chem. Rev. 216−, 217
Jones A. L., 1991, Comparison of dexamethasone and ondansetron in the prophylaxis os emesis induced by moderately emetogenic chemotherapy. Lancet 338, 483−487
Smith D. B., 1991, Comparison of ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 338, 487−490
Ito K., 1999, Jpn. J. Clin. Oncol., 29
Reedijk J., 1996, Increased understanding in platinum antitumour chemistry. Chem. Commun. 801−806
Gamelin E., 2002, Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventative measures. Semin. Oncol. 29 (suppl 15), 21−23
Seymour L. W., 1992, Crit. Rev. Ther. Drug Carrier Syst., 9
Duncan R., 1997, Polymer therapeutics for tumour specific delivery. Chem. Ind. (London), 262−264
Matsumura Y., 1986, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 46 (12), 6387−6392
Vasey, P. A., Kaye, S. B., Morrison, R., Twelves, C., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., Burtles, S., Fraier, D., Cassidy, J., and Frigerio, E. (1999) Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents- drug-polymer conjugates.Clin. Cancer. Res. 5(1), 83−94.
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., and Beijnen, J. H. (2001) Phase I clinical and pharmacokinetic study of PNU 166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.Anticancer Drugs 12, 315−323.
Duncan R., 1999, US Patent, 5, 965
Jun Y. J., 2005, J. Inorg. Biochem., 99
Siegmann-Louda D. W., 2004, Polymeric platinum containing drugs in the treatment of cancer. Macromolecules Containing Metal and Metal-like Elements, 191
Thurmond K. B., II, 2005, ACS Symposium Series 923 (Polymer Drug Delivery, 154
Rice J. R., 2006, Preclinical efficacy and pharmacokinetics of AP5346, a novel DACH-platinum tumor-targeting drug delivery system. Clin. Cancer Res. 12, 2248−2254
Rejmanova P., 1977, Aminolyses of monomeric and polymeric 4-nitrophenyl esters of N-methacryloamino acids. Makromol. Chem. 178, 2159−2168
Berners-Price S., 1992, J. Chem. Soc., Chem. Commun. 789−791.
Appleton, T. (1984) Reactions of platinum (II) aqua complexes. 1. Multinuclear (195Pt,15N,31P) NMR study of reactions between the cis-diamminediaquaplatinum (II) cation and the oxygen donor ligands hydroxide, perchlorate, nitrate, sulfate, phosphate and acetate.Inorg. Chem.23, 3514−3521.
Yeong-Sang K., 2004, J. Inorg. Biochem., 98, 104
Smit A., 2005, Evaluation of cisplatin and a novel platinum polymer conjugate for drug toxicity and drug distribution in mice. Anti-Cancer Drugs 16, 501−506
Sood P., US Patent Appl. US 2004/0175387 A1.
Pinciroli V., 1997, Magn. Reson. Chem., 35, 8, 10.1002/(SICI)1097-458X(199701)35:1<2::AID-OMR24>3.0.CO;2-D
Gibson D., 1990, Multinuclear (195Pt, 15N, 13C) NMR studies of the reactions between cis-diaminediaquaplatinum (II) Complexes and aminomalonate. Inorg. Chem. 29, 5125−5129
Kirvan G. E., 1985, Formation and NMR spectra of platinum (II)-tripeptide complexes. Inorg. Chem. 24, 3017−3021
Nagao N., 1997, Platinum (II) complexes with diglycine: X-ray crystal structure, 15N NMR spectra, and growth-inhibitory activity against mouse meth A solid tumor in vivo. Inorg. Chem. 36, 4195−4201